Unrevealing the natural course of the so-called “inactive HBsAg or HBV carrier state”

Por Hadziyannis, Stephanos J.
Publicado em 2007

Update on Hepatitis B Virus Infection: Focus on Treatment

Por Hadziyannis, Stephanos J.
Publicado no J Clin Transl Hepatol (2014)

Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues

Por Rapti, Irene, Hadziyannis, Stephanos
Publicado no World J Hepatol (2015)

The role of entecavir in the treatment of chronic hepatitis B

Por Dimou, Evangelini, Papadimitropoulos, Vasilios, Hadziyannis, Stephanos J
Publicado em 2007

Early Predictors of Anemia in Patients with Hepatitis C Genotype 1 Treated with Peginterferon alfa-2a (40KD) plus Ribavirin

Por Reau, Nancy, Hadziyannis, Stephanos J., Messinger, Diethelm, Fried, Michael W., Jensen, Donald M.
Publicado em 2008

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients

Por Marcellin, Patrick, Bonino, Ferruccio, Yurdaydin, Cihan, Hadziyannis, Stephanos, Moucari, Rami, Kapprell, Hans-Peter, Rothe, Vivien, Popescu, Matei, Brunetto, Maurizia R.
Publicado em 2012